文献
J-GLOBAL ID:201302263840237252
整理番号:13A1366154
薬剤耐性結核の治療におけるWHOグループ5薬剤: 不明な有効性または未開発の可能性か?
World Health Organization Group 5 Drugs for the Treatment of Drug-Resistant Tuberculosis: Unclear Efficacy or Untapped Potential?
著者 (12件):
DOOLEY Kelly E.
(Johns Hopkins Univ. School of Medicine, Maryland)
,
DOOLEY Kelly E.
(Efficacy Subgroup, RESIST-TB)
,
OBUKU Ekwaro A.
(Univ. of Maryland School of Medicine, Kampala, UGA)
,
OBUKU Ekwaro A.
(Efficacy Subgroup, RESIST-TB)
,
DURAKOVIC Nadza
(Partners In Health, Massachusetts)
,
DURAKOVIC Nadza
(Efficacy Subgroup, RESIST-TB)
,
BELITSKY Vera
(Partners In Health, Massachusetts)
,
BELITSKY Vera
(Efficacy Subgroup, RESIST-TB)
,
MITNICK Carole
(Harvard Medical School, Massachusetts)
,
MITNICK Carole
(Efficacy Subgroup, RESIST-TB)
,
NUERMBERGER Eric L.
(Johns Hopkins Univ. School of Medicine, Maryland)
,
NUERMBERGER Eric L.
(Efficacy Subgroup, RESIST-TB)
資料名:
Journal of Infectious Diseases
(Journal of Infectious Diseases)
巻:
207
号:
9
ページ:
1352-1358
発行年:
2013年05月01日
JST資料番号:
A0992B
ISSN:
0022-1899
CODEN:
JIDIAQ
資料種別:
逐次刊行物 (A)
発行国:
アメリカ合衆国 (USA)
言語:
英語 (EN)